WA manufacturer’s stunning 377 per cent share price rise

Shares in nerve growth therapy developer Orthocell (ASX: OCC) have surged 377 per cent on positive news from clinical trials of its CelGro tissue repair device. The company, which developed and manufactures CelGro at its internationally-approved facility in Perth, passed a critical trial with patients with damaged nerves. The first four patients to receive surgery…

Reece Pharmaceuticals scales up manufacturing

Synthetic antibiotic developer Recce Pharmaceuticals Ltd (ASX: RCE) has scaled up its Sydney production facility to support its commercialisation activities. The company, which has patented a new class of antibiotics to tackle resistant superbugs, has increased capacity at Macquarie Park in Sydney fivefold to cope with increasing demand. The Company has developed an automated process…

Global hemp manufacturer frustrated in Australia

The Australian-listed company that brought you the hemp burger remains frustrated in Australia despite being close to its goal of profitability internationally, according to the company. Elixinol Global (ASX: EXL), listed in Australia with a market capitalisation of $632 million but headquartered in the United States, just reported revenue of $11.7 million for the first…